Adding antiplatelet therapy to anticoagulation does not cut stroke risk but raises major bleeding
Combined Anticoagulant and Antiplatelet Therapy Increases Bleeding Risk
This meta-analysis of 14,884 patients with recent ischemic stroke, nonvalvular atrial fibrillation, and large artery atherosclerosis found t…
Combining two types of blood thinners may increase bleeding risks without reducing the chance of a second stroke in patients with certain he…
Oral anticoagulant monotherapy significantly reduces major bleeding compared to combined therapy in stable coronary artery disease
Anticoagulant alone may cut bleeding risk in heart patients
This meta-analysis of randomized controlled trials involving 5924 patients found that oral anticoagulant monotherapy results in a comparable…
For some heart patients, skipping aspirin and using only an anticoagulant may lower bleeding risk without raising heart risks.
Anticoagulation associated with lower risk of recurrent stroke in patients with left ventricular systolic dysfunction
Anticoagulants may lower stroke risk for patients with heart dysfunction
This meta-analysis of secondary analyses of randomized clinical trials examines anticoagulation for ischemic stroke prevention in patients w…
New analysis suggests that blood thinners might reduce the risk of both first and repeat strokes in people with specific types of heart musc…
Dual antiplatelet therapy reduces stroke recurrence in patients with acute mild ischaemic stroke
Dual Antiplatelet Therapy Reduces Stroke Risk in Mild Cases
This meta-analysis evaluated dual antiplatelet therapy compared to monotherapy in patients with acute mild ischaemic stroke or TIA. The anal…
New data shows dual antiplatelet therapy can lower stroke recurrence for patients with mild ischemic strokes or TIA, despite higher bleeding…
OAC monotherapy offers optimal balance for secondary prevention in atrial fibrillation and stroke patients compared to combination strategies
Taking one blood thinner alone works best for heart and stroke patients compared to mixing medicines
A network meta-analysis of 14,104 patients suggests oral anticoagulant monotherapy is the most favorable strategy for secondary prevention i…
Doctors found that using just one blood thinner is safer and more effective than mixing it with other pills. This approach lowers stroke ris…
Meta-analysis shows association between tirofiban and improved functional outcomes in non-LVO acute ischemic stroke
Tirofiban May Help More Stroke Patients Walk and Talk After 90 Days
This meta-analysis of 3,225 patients evaluated the association between tirofiban and conventional antiplatelet therapy for acute ischemic st…
A stroke drug called tirofiban may help more people recover fully after 90 days, especially when used with standard clot-busting treatment.
Asundexian added to antiplatelet therapy reduces recurrent stroke risk without increasing major bleeding in high-risk patients
New drug lowers stroke risk in high-risk patients without increasing bleeding
This phase 3 trial evaluated asundexian added to standard antiplatelet therapy in patients with noncardioembolic ischemic stroke or high-ris…
A new daily pill lowers stroke risk in high-risk patients without increasing bleeding, offering a safer option for preventing clots after a …
Systematic review finds low-certainty evidence against endovascular therapy superiority in vertebral artery stenosis
Stents May Not Stop Strokes in Narrowed Neck Arteries
This systematic review evaluated endovascular therapy versus medical treatment alone in adults with symptomatic vertebral artery stenosis.
Stents might not stop strokes in narrowed neck arteries better than medicine alone for people with blocked blood flow to the back of the bra…